Deutsche Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $242K | Sell |
|
|||||
2024
Q1 | $24.2M | Buy |
|
|||||
2023
Q4 | $15.4M | Buy |
|
|||||
2023
Q3 | $741K | Buy |
|
|||||
2023
Q2 | $932K | Sell |
|
|||||
2023
Q1 | $1.01M | Buy |
|
|||||
2022
Q4 | $940K | Buy |
|
|||||
2022
Q3 | $704K | Sell |
|
|||||
2022
Q2 | $850K | Buy |
|
|||||
2022
Q1 | $924K | Sell |
|
|||||
2021
Q4 | $919K | Buy |
|
|||||
2021
Q3 | $781K | Buy |
|
|||||
2021
Q2 | $575K | Buy |
|